Abstract C131: Influences of ancestry-associated non-pathogenic germline variants as cancer vulnerabilities
The advent of precision oncology has transformed cancer care. Yet only approximately 25% of patients are eligible for targeted therapies, as current approaches exploit tumors harboring well-characterized somatic driver alterations. This limitation has restricted the broader clinical impact of precision medicine and c...